(Q45733142)

English

Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia

scientific article published on 16 May 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

0 references

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

David Goldblatt

object named as

D Goldblatt

11

0 references

object named as

S Jaffar

4

0 references

author name string

M Saaka

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

B J Okoko

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

R C Kohberger

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

G Enwere

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

E E Biney

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

C Oluwalana

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

A Vaughan

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

S M A Zaman

9

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

L Asthon

10

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

B M Greenwood

12

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

F T Cutts

13

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

R A Adegbola

14

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

language of work or name

0 references

publication date

16 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

29-30

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

3719-3726

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Streptococcus pneumoniae : Epidemiology, Risk Factors, and Clinical Features

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Pneumonia in children in the developing world: new challenges, new solutions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Hidden epidemic of macrolide-resistant pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Pneumococcal disease among children in a rural area of west Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Acute bacterial meningitis in The Gambia: a four-year review of paediatric hospital admissions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Epidemiology of invasive pneumococcal disease in the Western Region, The Gambia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Effect of Community‐Wide Conjugate Pneumococcal Vaccine Use in Infancy on Nasopharyngeal Carriage through 3 Years of Age: A Cross‐Sectional Study in a High‐Risk Population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Impact of pneumococcal conjugate vaccine on the prevention of invasive pneumococcal diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Regional differences in HIV trends in The Gambia: results from sentinel surveillance among pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Immunogenicity after one, two or three doses and impact on the antibody response to coadministered antigens of a nonavalent pneumococcal conjugate vaccine in infants of Soweto, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein--conjugated pneumococcal vaccine in Filipino infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Immunogenicity and safety of the eleven valent pneumococcal polysaccharide-protein D conjugate vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Impact of nutritional status on antibody responses to different vaccines in undernourished Gambian children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

Effect of month of vaccine administration on antibody responses in The Gambia and Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

The etiology of pneumonia in malnourished and well-nourished Gambian children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.066

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.04.066

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45733142&oldid=2079050572"